Exploring the Biological Activity of a Humanized Anti-CD99 ScFv and Antibody for Targeting T Cell Malignancies

CD99, a type I transmembrane protein, emerges as a promising therapeutic target due to its heightened expression in T cell acute lymphoblastic leukemia (T-ALL). This characteristic renders it a potential marker for minimal residual disease detection and an appealing target for antibody-based treatme...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Nuchjira Takheaw, Thanathat Pamonsupornwichit, Ratthakorn Chaiwut, Kamonporn Kotemul, Kanokporn Sornsuwan, On-anong Juntit, Umpa Yasamut, Passaworn Cheyasawan, Witida Laopajon, Watchara Kasinrerk, Chatchai Tayapiwatana
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	MDPI AG 2024-11-01
Serie:	Biomolecules
Soggetti:	CD99 T cell malignancies antibody humanization antibody therapy apoptosis
Accesso online:	https://www.mdpi.com/2218-273X/14/11/1422
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!